For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
12 July 2023
Mary Elizabeth C. Stern and Longxuan Wang
In NERA’s 15th annual review of the asbestos-related liabilities reported in companies’ 10-Ks, Managing Director Mary Elizabeth C. Stern and Consultant Longxuan Wang use publicly available data to analyze trends in asbestos-related liabilities spanning 2008–2022.
Highlights from this report include:
In addition to reviewing 10-Ks, the authors collected data from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program on the incidence of mesothelioma diagnoses in the United States. These data are available through 2020. Mesothelioma incidence fell 12% in 2020, reversing the increase observed in 2019 and continuing the trend of declining incidence that began in 2016.
Please contact the authors if you would like NERA to analyze your asbestos data in conjunction with that of other public companies in a benchmarking study.